Lind Global Asset Management XIV

Lind Global Asset Management XIV is an institutional investment vehicle managed by The Lind Partners, a New York-based firm specializing in growth capital for small- and mid-cap companies. The entity is particularly active within the life sciences, biotechnology, and healthcare sectors, providing flexible financing solutions such as convertible securities and follow-on equity investments. By offering strategic capital, the firm enables biotech companies to progress through critical clinical milestones and regulatory hurdles. Lind Global Asset Management XIV frequently partners with publicly traded entities on the NASDAQ and ASX, serving as a key source of institutional funding for emerging healthcare innovators. The firm’s investment approach is designed to support long-term value creation for its portfolio companies while providing them with the liquidity necessary for research and development.